Publication

July 13, 2022

SyneuRx Publishes a Research Paper in《Journal of Alzheimer's Disease Reports》and Presents Disease-modifying Medication Results of Lithium Benzoate, Demonstrated as a Safe and Effective Drug Candidate for Alzheimer's Disease or other Neurodegenerative Disorders. (Accepted)

May 16, 2022

SyneuRx Publishes Pan-coronal Antiviral Therapeutic Research Results of Pentarlandir®, demonstrated as a Safe and Effective Drug Candidate, in 《ACS Pharmacology & Translation Science》